Status:
ENROLLING_BY_INVITATION
Criterion-learning Naming Treatment For Addressing Comprehension Deficits in Aphasia
Lead Sponsor:
Albert Einstein Healthcare Network
Collaborating Sponsors:
Thomas Jefferson University
National Institute on Deafness and Other Communication Disorders (NIDCD)
Conditions:
Aphasia
Eligibility:
All Genders
18-89 years
Phase:
NA
Brief Summary
Aphasia is a disorder of spoken and written language, most commonly following a stroke. It is estimated that between 2.5 and 4 million Americans are living with aphasia today. A common problem in apha...
Detailed Description
This study examines a retrieval practice-based naming treatment termed criterion learning. In criterion learning, each item's assigned criterion level dictates the number of times that item is correct...
Eligibility Criteria
Inclusion
- English as a native or primary language
- Adults with stroke who are at least 6 months post-onset
- Exhibit semantic comprehension deficit, defined as a minimum of 80 errors on word-picture verification pre-test
Exclusion
- History of comorbid neurological diagnoses, such as Multiple Sclerosis or Parkinson's Disease
- History of a learning disability that significantly impacted language development, such as developmental language disorder
- Insufficient stamina to participate in the protocol
Key Trial Info
Start Date :
June 24 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2028
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT07179458
Start Date
June 24 2024
End Date
August 1 2028
Last Update
October 7 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Jefferson Moss Rehabilitation Research Institute
Elkins Park, Pennsylvania, United States, 19027